These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 2579365

  • 1. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ, Walsh FX, Bird ED, Levy HL.
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [Abstract] [Full Text] [Related]

  • 2. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 3. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Jul; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 4. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ, Bird ED, McEntee WJ.
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [Abstract] [Full Text] [Related]

  • 5. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Jul; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 6. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K.
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 8. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

  • 9. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O, Johansson BB, Svennerholm L.
    Acta Neurol Scand; 1981 Apr 12; 63(4):247-54. PubMed ID: 6163303
    [Abstract] [Full Text] [Related]

  • 10. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G.
    Prog Biochem Pharmacol; 1980 Apr 12; 16():133-40. PubMed ID: 6160594
    [Abstract] [Full Text] [Related]

  • 11. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN.
    J Neurol Neurosurg Psychiatry; 1984 May 12; 47(5):481-4. PubMed ID: 6204017
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid monoamine metabolite levels in human newborn infants born in winter differ from those born in summer.
    Chotai J, Murphy DL, Constantino JN.
    Psychiatry Res; 2006 Dec 07; 145(2-3):189-97. PubMed ID: 17074397
    [Abstract] [Full Text] [Related]

  • 13. Role of neurotransmitter in forensic medicine (report II). A simple and simultaneous analysis of the major monoamine metabolites in human cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Endo T, Nishida A, Kano S.
    Nihon Hoigaku Zasshi; 1987 Feb 07; 41(1):4-9. PubMed ID: 2439728
    [No Abstract] [Full Text] [Related]

  • 14. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov 07; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 15. Monoamine metabolites and ventricular fluid pressure in children.
    Yates CM, Minns RA.
    Childs Brain; 1981 Nov 07; 8(2):138-44. PubMed ID: 6166434
    [Abstract] [Full Text] [Related]

  • 16. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P, Verrier M, Warsh JJ, Price KS.
    J Neurol Neurosurg Psychiatry; 1976 Dec 07; 39(12):1191-200. PubMed ID: 1011029
    [Abstract] [Full Text] [Related]

  • 17. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM, Tsementzis SA, Wilson H.
    J Neurol Neurosurg Psychiatry; 1979 Oct 07; 42(10):887-91. PubMed ID: 512664
    [Abstract] [Full Text] [Related]

  • 18. CSF monoamine metabolites in mania.
    Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, Maas JW.
    Am J Psychiatry; 1983 Apr 07; 140(4):396-400. PubMed ID: 6188381
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M, Chang WH, Kirk KL, Linnoila M.
    Anal Biochem; 1983 May 07; 131(1):246-53. PubMed ID: 6193730
    [Abstract] [Full Text] [Related]

  • 20. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T, Hara S, Kuriiwa F, Kano S.
    Forensic Sci Int; 1990 Jan 07; 44(1):61-8. PubMed ID: 1689267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.